Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study

[1]  S. Yusuf,et al.  Reduction of Cardiovascular Risk by Regression of Electrocardiographic Markers of Left Ventricular Hypertrophy by the Angiotensin-Converting Enzyme Inhibitor Ramipril , 2001, Circulation.

[2]  M. Nieminen,et al.  Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. , 2001, Journal of hypertension.

[3]  R. Prineas,et al.  Independent risk for cardiovascular disease predicted by modified continuous score electrocardiographic criteria for 6-year incidence and regression of left ventricular hypertrophy among clinically disease free men: 16-year follow-up for the multiple risk factor intervention trial. , 2001, Journal of electrocardiology.

[4]  M. Nieminen,et al.  Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint. , 2000, American journal of hypertension.

[5]  C Cosco,et al.  Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. , 2000, Hypertension.

[6]  R. Devereux,et al.  Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. , 1999, Journal of the American College of Cardiology.

[7]  M. Nieminen,et al.  Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. , 1998, Hypertension.

[8]  R. Schmieder,et al.  Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agents. , 1998, American journal of hypertension.

[9]  P. Kligfield,et al.  Time-voltage QRS area of the 12-lead electrocardiogram: detection of left ventricular hypertrophy. , 1998, Hypertension.

[10]  G. Schillaci,et al.  Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. , 1998, Journal of the American College of Cardiology.

[11]  G. Reboldi,et al.  Prognostic significance of serial changes in left ventricular mass in essential hypertension. , 1998, Circulation.

[12]  M. Nieminen,et al.  The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. , 1997, American journal of hypertension.

[13]  M. Nieminen,et al.  H35: Baseline characteristics of the life (Losartan intervention for endpoint reduction) in hypertension study , 1997 .

[14]  D. Levy,et al.  Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach. , 1995, Journal of the American College of Cardiology.

[15]  Daniel L. McGee,et al.  The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. , 1995, JAMA.

[16]  P. Kligfield,et al.  Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. , 1995, Journal of the American College of Cardiology.

[17]  G. Schillaci,et al.  Improved electrocardiographic diagnosis of left ventricular hypertrophy. , 1994, The American journal of cardiology.

[18]  D. Levy,et al.  Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. , 1994, Circulation.

[19]  E. Nelson,et al.  The treatment of mild hypertension study. , 1993, JAMA.

[20]  C. Lewis,et al.  Treatment of Mild Hypertension Study: Final Results , 1993 .

[21]  J. Cutler,et al.  Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. , 1993, JAMA.

[22]  P Kligfield,et al.  Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. , 1992, Journal of the American College of Cardiology.

[23]  J. Laragh,et al.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. , 1991, Annals of internal medicine.

[24]  D. Levy,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[25]  J. C. Christiansen,et al.  Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. , 1990, Circulation.

[26]  P Kligfield,et al.  Day-to-day variability of voltage measurements used in electrocardiographic criteria for left ventricular hypertrophy. , 1990, Journal of the American College of Cardiology.

[27]  P Kligfield,et al.  Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. , 1987, Circulation.

[28]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[29]  P Kligfield,et al.  Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. , 1985, Journal of the American College of Cardiology.

[30]  K. Peterson,et al.  Reliability of echocardiographic and electrocardiographic parameters in assessing serial changes in left ventricular mass. , 1981, The American journal of medicine.

[31]  C. E. Davis,et al.  The effect of regression to the mean in epidemiologic and clinical studies. , 1976, American journal of epidemiology.

[32]  T. Cottle.  The Life Study , 1973 .

[33]  J L Willems,et al.  Day‐to‐Day Variation of the Normal Orthogonal Electrocardiogram and Vectorcardiogram , 1972, Circulation.

[34]  M. Sokolow,et al.  The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. , 1949, American heart journal.

[35]  R. Devereux,et al.  Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study. , 2000, Hypertension.

[36]  R S Crow,et al.  Is the echocardiogram an appropriate ECG validity standard for the detection and change in left ventricular size? , 1996, Journal of electrocardiology.

[37]  C. Furberg,et al.  Improved ECG models for estimation of left ventricular hypertrophy progression and regression incidence by redefinition of the criteria for a significant change in left ventricular hypertrophy status. The MRFIT Research Group. Multiple Risk Factor Intervention Trial. , 1993, Journal of electrocardiology.

[38]  K. Pennert,et al.  Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. , 1992, American journal of hypertension.

[39]  L. Wilkins.  Five-year findings of the Hypertension Detection and Follow-up Program. Prevention and reversal of left ventricular hypertrophy with antihypertensive drug therapy. Hypertension Detection and Follow-up Program Cooperative Group. , 1985, Hypertension.